Milestone Pharmaceuticals Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Milestone Pharmaceuticals Inc. reported Cash And Cash Equivalents At Carrying Value of $73.05 million for the year ending 2025.

  • Milestone Pharmaceuticals Inc. showed an increase of +188.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Milestone Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on March 20, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), Milestone Pharmaceuticals Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 15.0%.
  • Historical annual values: Fiscal year 2025: $73.05 million | Fiscal year 2024: $25.31 million | Fiscal year 2023: $13.76 million | Fiscal year 2022: $7.64 million | Fiscal year 2021: $114.14 million | Fiscal year 2020: $72.31 million | Fiscal year 2019: $119.82 million | Fiscal year 2018: $85.95 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: